Pfizer Inc.’s PFE, +0.45% $5.4 billion acquisition of Global Blood Therapeutics Inc. GBT, -0.02% is the latest sign that cash-flush drug makers are ready to jump back into dealmaking. That Read more
Pfizer Inc.’s PFE, +0.45% $5.4 billion acquisition of Global Blood Therapeutics Inc. GBT, -0.02% is the latest sign that cash-flush drug makers are ready to jump back into dealmaking. That Read more